Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
6/7/22 16:33 | 6/6/22 | CGEM | Health | BioPrd | Biological Products, (No Diag | Ahmed Nadim | MA | DO | P,CEO | P | 100 | 12.40 | 0 | 8 | New | 8 | D | ||||||||||||||
6/3/22 18:24 | 6/1/22 | CGEM | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | P | 8,265 | 11.00 | 0 | 751 | 364 | D | ||||||||||||||||
5/16/22 19:34 | 5/12/22 | CGEM | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | P.m | 10,064 | 9.07 | 0 | 1,110 | 319 | D | ||||||||||||||||
4/5/22 18:45 | 4/1/22 | CGEM | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | P | 2,967 | 10.75 | 0 | 276 | 12 | 2,498 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |